Essential fat requirements of preterm infants.
The interest in factors that modify early infant development has led investigators to focus on n-3 and n-6 long-chain polyunsaturated fatty acids (LCPUFAs) in the past 2 decades. The presence of docosahexaenoic acid (DHA) and arachidonic acid (AA) in breast milk, compared with their absence from infant formulas available in the United States, has prompted clinical trials designed to examine whether LCPUFA enrichment of infant formula has beneficial effects on maturational events of the visual system. These trials have shown significant functional advantages of LCPUFA supplementation for preterm infants, whereas benefits for full-term infants remain controversial. The growth and safety of preterm infants was not compromised by LCPUFA enrichment, although these issues remain to be resolved in clinical trials with full-term infants.
Uauy
R
R
Institute of Nutrition and Food Technology (INTA), University of Chile, Santiago.
Hoffman
D R
DR
D000328:Adult; D016718:Arachidonic Acid / Q000378:metabolism; D001921:Brain / Q000254:growth & development; D003071:Cognition; D005228:Fatty Acids, Essential / Q000378:metabolism* / Q000502:physiology; D005260:Female; D006801:Humans; D007223:Infant; D007225:Infant Food; D007227:Infant Nutritional Physiological Phenomena; D007231:Infant, Newborn; D007234:Infant, Premature; D019787:Linoleic Acid / Q000378:metabolism; D008895:Milk, Human / Q000737:chemistry / Q000378:metabolism; D009751:Nutritional Requirements; D012160:Retina / Q000254:growth & development; D014792:Visual Acuity; D017962:alpha-Linolenic Acid / Q000378:metabolism
D005228:Fatty Acids, Essential; D017962:alpha-Linolenic Acid; D016718:Arachidonic Acid; D019787:Linoleic Acid